To identify genetic changes that lead to the attenuation of measles virus (MV), a strain of MV that is pathogenic in rhesus macaques was adapted to grow in Vero cells, Vero/hSLAM cells and, to simulate the process used to derive live attenuated vaccines, in primary chicken embryo fibroblasts (CEF). Comparison of the complete genomic sequences of the pathogenic wild-type (Davis87-wt) and four cell culture-adapted strains derived from it showed complete conservation of sequence in the Vero/hSLAM-passaged virus. Viruses adapted to Vero cells and CEF had predicted amino acid changes in the nucleocapsid protein, phosphoprotein, V protein, C protein, matrix protein, and the cytoplasmic tail of the hemagglutinin protein. All four cell culture-adapted strains, including the Vero/hSLAM cell-passaged virus, were able to productively infect Vero cells, but the peak viral titers differed. The Vero cell-adapted strains were unable to replicate in Chinese Hamster Ovary cells expressing CD46, indicating that they had not adapted to use the CD46 receptor. The Vero/hSLAM cell-passaged virus retained pathogenicity in rhesus macaques as measured by the appearance of a skin rash while the Vero cell-adapted and CEF-adapted strains had lost the ability to cause a rash. There were no significant differences in viral titers in peripheral blood mononuclear cells among monkeys infected with any of the viral stocks tested. These results identify a limited number of genetic changes in the genome of MV that lead to attenuation in vivo.
Introduction
The widespread use of live attenuated measles vaccines has resulted in a dramatic reduction in the global morbidity and mortality caused by measles infections (Anonymous, 2006; Wolfson et al., 2007) . The live-attenuated measles vaccines that are in use today have outstanding safety and efficacy profiles; however, the genetic basis for the attenuation of measles virus (MV) vaccine strains is unknown. Many of the current vaccine strains were derived from the prototype Edmonston isolate, while others were derived from unrelated wild-type viruses (Rota et al., 1994) . All of the vaccines were developed well in advance of modern molecular biologic techniques and the genetic characterization of vaccine viruses has been a relatively recent activity. The WHO currently recognizes 23 genotypes of MV (WHO, 2005) , and all of the vaccine strains are members of genotype A. Comparison of the sequences of the complete genomes of all of the Edmonston-derived vaccine strains with the sequence of the Edmonston wt virus (Ed-wt) (Parks et al., 2001a,b) identified a limited number of nucleotide substitutions in the vaccine strains relative to Ed-wt. However, the stock of Ed-wt had been passaged 13 times in cell culture prior to the sequence analysis (Rota et al., 1994) . Since the original clinical specimen for Ed-wt is not available for sequence analysis, a direct comparison of the genomic sequences of the wild-type virus and vaccine strains is not possible.
There have been no reports of measles outbreaks associated with genotype A in the last two decades, but genotype A viruses have been associated with a small number of sporadic cases (Riddell et al., 2005) . Because many of these events could be due to laboratory contamination or unrecognized vaccine reactions, the identification of genomic markers for attenuation of MV would facilitate surveillance for wild-type MVs. In addition, this genetic information could be used to monitor the safety and stability of new vaccine lots and would contribute to the development of improved vaccines for MV.
MV is a member of the genus Morbillivirus of the family Paramyxoviridae. Its monopartite, single-stranded, negativesense RNA genome contains six genes, which encode eight proteins (Griffin, 2001) . The noncoding regions of the termini contain the promoters for transcription and replication and the encapsidation signals. The nucleoprotein (N) encapsidates the viral genome and binds the polymerase complex. The P gene encodes three proteins, the phosphoprotein (P) and the C and V proteins. C is translated from an overlapping reading frame while V shares an amino terminal domain of 231 amino acids with P, but has a unique carboxyl terminus as a result of RNA editing (Cattaneo et al., 1989) . P is a necessary component of the polymerase complex and acts as a scaffolding protein in nucleocapsid assembly. The C and V proteins regulate polymerase activity (Bankamp et al., 2005; Reutter et al., 2001; Tober et al., 1998; Witko et al., 2006) and act as antagonists of the innate immune response (Shaffer et al., 2003; Takeuchi et al., 2003) . The matrix protein (M) plays a role in viral assembly and in the transport of viral glycoproteins to the apical membrane of polarized cells (Naim et al., 2000) . The fusion (F) and hemagglutinin (H) glycoproteins are expressed on the surface of infected cells and of the virion, where the F protein promotes fusion with adjacent membranes. The H protein binds to specific receptors on the host cell and is a required co-factor for fusion. The Large protein (L) is the catalytic subunit of the polymerase complex.
Two cellular receptors for MV have been characterized to date, CD46 (Membrane Cofactor Protein) (Dorig et al., 1993; Naniche et al., 1993) and signaling lymphocyte activation molecule (SLAM) (Tatsuo et al., 2000) . SLAM serves as a receptor for all wild-type isolates of MV as well as cell cultureadapted strains but is only expressed on a subset of cells of the immune system (Erlenhoefer et al., 2001; Hsu et al., 2001; Ono et al., 2001) . CD46 is expressed on all nucleated human cells, including the epithelial surfaces of the respiratory tract, where MV infections are thought to initiate (Liszewski et al., 1991) . However, CD46 can serve as a high affinity receptor only for cell culture-adapted, especially Vero cell-adapted MV strains (Buckland and Wild, 1997) . Vero cells (African green monkey kidney cells) express a CD46 homologue, as do the cells of other Old World monkeys (Hsu et al., 1997) , including rhesus macaques. However, Vero cells do not express SLAM. The sensitivity of isolation of MV from clinical samples has been greatly improved because of the recent development of Vero/ hSLAM cells (Ono et al., 2001) . Chicken embryo fibroblasts (CEF), which were used to generate many of the currently used measles vaccines (Rota et al., 1994) , do not express either of the two known receptors for MV . Past attempts to characterize nucleotide changes induced by adaptation to cell culture have focused on Vero cells, while little is known about adaptation of MV to avian cells.
Rhesus macaques are an excellent animal model for measles infections, since they reproduce most of the pathologic and immunologic aspects of the human disease (El Mubarak et al., 2007; McChesney et al., 1997) . An outbreak of measles in a rhesus monkey colony led to the isolation of Davis87-wt, a wildtype MV that retained pathogenicity in monkeys through exclusive passaging in lymphoid tissue or peripheral blood mononuclear cells of rhesus macaques .
In this study, we have adapted Davis87-wt to growth in three different cell lines, including avian cells, and identified nucleotide changes that resulted from these adaptations. The cell cultureadapted virus stocks were examined for their growth characteristics in cell culture and for pathogenicity in rhesus macaques.
Results

Development of cell culture-adapted virus stocks
Prior to this work, the Davis87-wt strain was propagated exclusively in rhesus macaques or rhesus lymphoid cells . Davis87-wt was passaged nine times in Vero/hSLAM cells to generate the D-V/S stock as described in Materials and methods. Syncytia, the characteristic cytopathic effect (CPE) of infection with MV, were visible from the first passage. Adaptation of Davis87-wt to Vero cells followed a similar protocol, but a greater starting titer (1000 pfu/ 25 cm 2 flask instead of 25 pfu/25 cm 2 flask) was used, followed by several blind passages. CPE was first visible at passage five. Adaptation to Vero cells was carried out twice to generate two viral stocks, D-VI and D-VII. Two attempts were made to directly infect primary chicken embryo fibroblasts (CEF) with Davis87-wt, using 1250 pfu/25 cm 2 flask as an inoculum. The cells were passaged up to nine times without visible CPE. No MV could be detected by indirect immunofluorescence or by RT-PCR (data not shown). To establish the CEF-adapted virus stock, D-CEF, cells were infected at an MOI of 1 with D-V/S and passaged as described for the Vero cell cultures. Table 1 summarizes the passage history and the titers of the final stocks. It is important to note that the viruses were not plaque purified. The high titers suggest that the viruses are well adapted to grow in their respective cell lines.
Sequence analysis
The complete genomic sequences of all four cell cultureadapted strains and Davis87-wt were determined. Sequence analysis confirmed that Davis87-wt belongs in the D3 genotype, which was responsible for the resurgence of measles in the US from 1989-1991 (data not shown) (Rota et al., 1992) . Davis87wt and D-V/S were genetically identical, demonstrating that nine passages in Vero/hSLAM cells had not selected for nucleotide changes.
Only one predicted amino acid change was identified in D-VI, amino acid 30 in the cytoplasmic tail of the H protein was changed from Leu in Davis87-wt to Pro (Table 2) . Nucleotide 12751 had changed from a guanosine in the wild-type virus to a mix of guanosine and adenosine in the passaged viral stock, demonstrating that the stocks consisted of a mixture of viral subpopulations. An adenosine at this position leads to a predicted amino acid change from Arg to His at amino acid 1173 in the L protein. Two silent nucleotide changes were detected in D-VI. Sequence analysis of D-VII also detected only one predicted amino acid change, in the N protein, with amino acid 23 changed from Gly to Arg. Additionally, D-VII had two silent changes and three mixed positions, one of which was in close proximity to the editing site in the P gene, extending the series of three guanosines at the editing site to four in the subpopulation that contains this substitution ( Table 2 ).
The only virus stock with multiple, predicted amino acid substitutions was D-CEF. The M protein contained one predicted amino acid change from Thr to Ile at position 84. Three predicted amino acid changes were identified in all three proteins encoded by the P gene. These included a Val to Ala substitution at amino acid 102 in the C protein and two mutations affecting amino acids 110 and 120 in the shared amino terminal domain of P and V. In addition, D-CEF contained two silent mutations and five mixed positions. Two of these mixed positions were located in the intergenic trinucleotide (CTT) between the M and F genes, replacing one or both of the thymidines with cytidines (Table 2) . Aside from these last two mixed positions, there were no substitutions in any noncoding region of the four cell cultureadapted viruses, nor were there any amino acid changes to the F genes. The only nucleotide sequence changes found in the L genes were silent or mixed positions.
Growth of cell culture-adapted viruses in various cell lines
Indirect immunofluorescence assays demonstrated that within 24 h after infection, all five viruses produced large syncytia in B95a cells, a marmoset B lymphoblastoid cell line expressing the marmoset homolog of hSLAM ( Fig. 1) . Similarly, large syncytia were detected after infection of Vero/ hSLAM cells with all five viruses (data not shown). As expected, the Vero-adapted strains produced large foci of infection on Vero cells; however, these foci developed after 3 days of incubation. Large plaques were also detectable on Vero cells infected with D-CEF. The CEF-adapted virus appeared to spread faster on Vero cells than the Vero-adapted strains. As expected, the wild-type MV, Davis87-wt, was not able to infect Vero cells. While Davis87-wt did not produce visible foci in Vero cells, occasionally, single infected cells were detectable by indirect immunofluorescence (data not shown). Surprisingly, small foci of infected cells without any detectable fusion activity were observed in Vero cells infected with D-V/S. This difference between Davis87-wt and D-V/S was due to differences in the input MOI as all infections were carried out Table 2 Nucleotide and predicted amino acid differences between the Davis87-wt virus and cell culture-adapted viral stocks derived from Davis 87 wt with an MOI of 0.1, except for Davis87-wt, which had to be used at an MOI of 0.001 due to its low titer. When D-V/S was used at an MOI of 0.001, no signs of infection were detectable by indirect immunofluorescence assay (data not shown). A possible alternative explanation for the difference is that the D-V/S stock may contain a minor subpopulation that can replicate in Vero cells. However, no heterogeneous nucleotide positions were detected during sequencing of the D-V/S viral stock and this is in contrast to the sequencing results from the other virus stocks, which clearly contained mixed positions. Therefore, if there are subpopulations present in D-V/S, they are minor components of the stock.
The ability to infect CEF is limited to vaccine strains of MV which have been passaged in avian cells (Escoffier and Gerlier, 1999 , and data not shown). Only D-CEF produced large foci of infection on CEF. These foci developed over 4 days and demonstrated little fusion. Indirect immunofluorescence assays did not detect any foci of infected cells when the two Veroadapted strains were used to infect CEF.
To further analyze the replication potential of the passaged viruses, growth curves were carried out in Vero cells (Fig. 2) . Davis87-wt could not be tested because of insufficient amounts of the original virus stock. Viral titers were determined as TCID 50 on Chinese hamster ovary cells expressing hSLAM Fig. 1 . Infection of B95a cells, Vero cells, and CEF with cell culture-adapted viruses. Cells in chamber slides were infected with the indicated viruses at an MOI of 0.1, except for Davis87-wt, which had to be used at an MOI of 0.001 due to its low titer. At the indicated time points, indirect immunofluorescence assays were performed with an anti-N monoclonal antibody (green fluorescence). Propidium iodide (red fluorescence) was used to stain the nuclei. Photos were taken with 200× magnification.
(CHO-hSLAM). Titers of cell-associated virus increased to greater than 10 5 TCID 50 /ml by day five for all four viruses tested ( Fig. 2A ). D-CEF reproducibly reached the highest titers, followed by D-VI and D-VII. D-V/S always produced the lowest cell associated titers, approximately 100-fold lower than D-CEF. Despite the significant titers of cell-associated virus, D-V/S released only minimal amounts of virus into the medium (Fig. 2B ). D-CEF consistently demonstrated the highest titers in the supernatant medium, followed by D-VI and D-VII. These results indicate that D-V/S does productively infect Vero cells, but that virus release is restricted.
Receptor usage of cell culture-adapted viruses CHO cells stably expressing hSLAM or CD46 were infected with the cell culture-adapted strains and Davis87-wt. Indirect immunofluorescence assays demonstrated that all viruses produced large syncytia in CHO-hSLAM cells, but none of them produced detectable foci on CHO-CD46 cells (Fig. 3) . While individual CHO-CD46 cells expressing MV antigen were detectable, the infection did not spread to neighboring cells. The same result was obtained when infecting CHO cells that do not express either receptor for MV. As a positive control, the MV vaccine strain, Edmonston-Zagreb, was used to infect CHO-CD46 cells. This virus produced large syncytia on CHO-CD46 cells, demonstrating the ability of these cells to support MV replication. These results show that the cell culture-adapted strains did not spread in CHO-CD46 cells, demonstrating their inability to use CD46 as a receptor.
Pathogenesis of cell culture-adapted strains in rhesus macaques
Juvenile rhesus macaques were infected intranasally and conjunctivally with 3.2X10 4 TCID 50 of D-V/S, D-VI or D-CEF. Monkeys were observed for the characteristic rash and results were compared to historical controls of juvenile macaques infected with Davis87-wt. All four monkeys infected with D-V/S developed a typical MV rash, whereas none of the monkeys infected with D-VI or D-CEF showed clinical signs of disease (Table 3) . RNA was isolated from PBMC taken at day seven post infection from two monkeys infected with D-VI and two monkeys infected with D-CEF. PCR fragments were generated with MV-specific primers and sequenced to confirm the presence of the nucleotide substitutions in the H gene of D-VI and the P and M genes of D-CEF. The substitutions were still present; confirming that the mutations remained stable in the animals and did not revert to wild-type sequences (data not shown).
Blood samples were taken on days 0, 7, 14, and 28 post infection and viral titers in PBMC were determined by cocultivation with Raji cells (Fig. 4) . In historical controls, PBMC from macaques infected with Davis87-wt reached peak titers that were slightly greater than 10 4 TCID 50 per 10 6 PBMC on day seven post infection and still had detectable titers on day 14. Titers in monkeys infected with D-VI and D-CEF reached peaks ranging from 10 2 (D-CEF) or 10 3 (D-VI) to 10 4 TCID 50 per 10 6 PBMC on day seven. Titers in three of four monkeys infected with D-CEF and two of four infected with D-VI had fallen below the detection limit on day 14. Macaques infected with D-V/S demonstrated peak titers ranging from 10 3 to 10 5 TCID 50 per 10 6 PBMC, and two of four monkeys still had detectable titers at day 14. No significant differences in viremia were detectable between monkeys that did and did not develop a rash. These data demonstrate a slight reduction in peak titer and duration of viremia in all of the monkeys infected with cell culture-passaged virus stocks compared to the historical controls infected with Davis87-wt.
MV infection causes a transient suppression of the immune system which interferes with the development of an anamnestic immune response (Griffin, 1995; McChesney et al., 1989) . To test for the ability to mount an immune response against an unrelated antigen, macaques were re-vaccinated with tetanus toxoid on day seven after MV infection. Because the macaques had been vaccinated with tetanus toxoid as infants, this second vaccination should boost antibody titers unless inhibited by MV-induced immunosuppression. Antibody titers were compared on days 0 and 21 after tetanus vaccination and expressed as fold increase (Table 3) . Titers in all eight monkeys infected with D-VI or D-CEF and two monkeys infected with D-V/S rose at least fourfold, indicating an absence of immunosuppression. Two out of four monkeys infected with D-V/S had a titer increase against tetanus toxoid that was fourfold or less, suggesting that their immune responses had been suppressed. Taken together, these results show that the Vero cell-adapted and CEF-adapted viruses had lost pathogenicity in rhesus macaques, but the Vero/hSLAM-passaged virus had retained pathogenicity.
Discussion
The results of this study confirm that passage of wild-type measles viruses in Vero cells results in viruses with reduced Fig. 3 . Characterization of receptor usage of cell culture-adapted viruses by infection of CHO cells expressing cellular receptors for MV. CHO, CHO-hSLAM, and CHO-CD46 cells in chamber slides were infected with the indicated viruses at an MOI of 0.1, except for Davis87-wt, which had to be used at an MOI of 0.001 due to its low titer. At the indicated time points, indirect immunofluorescence assays were performed with an anti-MV N monoclonal antibody (green fluorescence). Propidium iodide (red fluorescence) was used to stain the nuclei. Photos were taken with 100× magnification. Ed-Zag = Edmonston-Zagreb vaccine strain. virulence in primate models, while passage of viruses in human cells or primate cell lines that contain the receptor for wild-type measles virus, hSLAM, preserves the virulent phenotype (Auwaerter et al., 1999; Kobune et al., 1990 Kobune et al., , 1996 . Passage of viruses in primary human PBMC is impractical, and the B95a cell line that was used in some of the previous studies is persistently infected with Epstein Barr Virus. Therefore, the recently developed Vero/hSLAM cell line may provide a better substrate for the production of challenge stocks for use in studies of the pathogenesis of measles virus. The work presented here shows for the first time that the virulent phenotype and wild-type sequence of a rhesus-adapted strain of measles were maintained following passage in Vero/hSLAM cells. The Vero/hSLAM passaged virus, D-V/S, produced a rash in all of the infected macaques; however, two of the four animals did not show evidence of immunosuppression, and the peak titers of virus in PBMC were slightly lower than those observed for historical controls. It is unclear whether the D-V/S stock demonstrated slightly reduced pathogenicity compared to the Davis87-wt or whether the differences were due to small variations in titer compared to the historical controls. Historical controls have demonstrated variability in both the level of viremia in PBMC and the recall response to tetanus toxoid vaccination (Premenko-Lanier et al., 2004; Zhu et al., 1997) . Immunosuppression following measles infection can be demonstrated as suppression of lymphoproliferative responses, delayed type hypersensitivity, or antibody response (Hirsch et al., 1984; Premenko-Lanier et al., 2004; Tamashiro et al., 1987) . In this study, immunosuppression was detected by analyzing the anamnestic response to tetanus toxoid (TT) vaccination. We have previously used this method to demonstrate a significant negative correlation between immunosuppression and protection against measles with experimental DNA vaccines (Premenko-Lanier et al., 2004) .
We attempted to repeat the process that was used to derive the current live attenuated vaccines for measles by adapting a genetically defined wild-type virus to infect CEF. We were unable to directly establish an infection in CEF with Davis87wt. Instead, a high-titered stock of D-V/S was used successfully to infect these avian cells. When attempting to generate the original measles vaccine, Katz et al. (1958) also failed to infect CEF directly from patient specimens and needed to passage the original Edmonston isolate 56 times in human cell lines and embryonated chicken eggs before successfully infecting CEF. It is interesting to note that, as observed previously (Escoffier and Gerlier, 1999) , the CEF-adapted virus was able to productively infect Vero cells, while neither of the Vero-adapted strains was able to replicate in CEF. The cellular receptor used by measles virus to infect CEF has not been identified. Both D-VI and D-CEF were attenuated in rhesus macaques as none of the animals developed the rash or immunosuppression that was produced by infection with Davis87-wt. However, for these viruses, the peak viral titers in PBMC did not differ significantly from the titers following challenge with D-V/S. Other studies have demonstrated significantly lower titers in PBMC of macaques infected with MV vaccine strains compared to titers measured in monkeys infected with wild-type viruses (Auwaerter et al., 1999; van Binnendijk et al., 1994) . Our results suggest that D-VI and D-CEF may not have been completely attenuated after 19-21 passages and that additional passage may lead to increased attenuation. For this study, we used the minimal number of passages required for generation of virus stocks with titers high enough for subsequent experiments. It is also possible that measurement of viral titers in PBMC may not be as sensitive as clinical presentation for detection of changes in viral pathogenicity.
A unique aspect of this report is that all of the viral stocks were characterized by complete genomic sequencing, which enabled us to document the genetic changes that accompanied adaptation of a virulent virus to growth in Vero cells and CEF. Analysis of these changes may provide clues as to the genetic basis for the attenuation of measles virus. The mutations in the cell culture-adapted viruses may affect their fitness. The results of the growth curves indicate increased fitness in Vero cells as measured by increased progeny, especially of the D-CEF virus compared to D-V/S. However, fitness gains in one environment (cell culture) can lead to fitness loss in another environment (animal host) (Domingo and Holland, 1997) . To measure the contributions of individual mutations to attenuation and fitness both in cell culture and in vivo, we are currently constructing recombinant measles viruses.
Two independent experiments demonstrated that mutations in different proteins can occur as result of adaptation to Vero cells, as has been reported previously (Takeda et al., 1998; Takeuchi et al., 2000) , and suggest that there are multiple pathways to cell culture adaptation and attenuation. The only amino acid substitution in D-VI compared to Davis87-wt was found in the cytoplasmic domain of the H protein, a substitution that would not be expected to affect receptor specificity. This interpretation was confirmed by the observation that D-VI did not infect CHO-CD46 cells, indicating that the amino acid change in the cytoplasmic tail did not allow the virus to use CD46 as a receptor. However, the substitution may affect interactions between the viral glycoproteins and therefore fusogenicity of the virus (Cathomen et al., 1998; Plemper et al., 2002) or it may affect interactions with the M protein and consequently transport of the glycoproteins to the apical membrane of polarized cells (Naim et al., 2000) . Compared to Davis87-wt, the only amino acid substitution in D-VII was located at position 23 of the N protein. The amino terminus of N is part of N-core, which spans amino acids 1-400 of the 525 amino acid N protein, and is required for encapsidation (Lamb and Kolakofsky, 2001) . Amino acids 4-188 are required for formation of the soluble N-P complex which provides the substrate for encapsidation of the genome (Bankamp et al., 1996) .Vero cells lack the ability to produce type I interferons (Emeny and Morgan, 1979) . It has been demonstrated that adaptation of wild-type MV strains to Vero cells can lead to a selection of variants that have lost the ability to counteract this arm of the innate immune system (McKimm and Rapp, 1977) . Since these defective mutants were relatively abundant (McKimm and Rapp, 1977) , it is possible that the loss of interferon-inhibiting activity confers a replicative advantage in cell lines that lack interferon. The possibility that the mutations we described alter the ability of the virus to inhibit part of the innate immune response is currently under investigation.
The D-CEF stock had four predicted amino acid substitutions compared to Davis87-wt. The change at amino acid 84 of the M protein of D-CEF is located in close proximity to amino acid substitutions Pro64Ser and Glu89Lys in the Edmonston strain of MV. These two substitutions were shown to improve growth in Vero cells (Miyajima et al., 2004; Tahara et al., 2005) by enhancing virus assembly (Tahara et al., 2007) . This domain of the M protein may play a role in cell culture adaptation. Also, mutations in M may affect interactions with F or H and sorting of these glycoproteins to the apical membrane (Naim et al., 2000) . The substitution found at amino acid 102 in the C protein of D-CEF falls into a domain that may regulate the replication of D-CEF because naturally occurring variations between amino acids 46 and 167 of the C protein affect its ability to down regulate RNA synthesis (Bankamp et al., 2005) . Of the two substitutions in the P and V proteins of D-CEF, the substitution at amino acid 110 (Tyr to His) is expected to result in an impaired ability to inhibit interferon signaling. The same substitution was found in Edtag, a recombinant virus based on a laboratory strain of Edmonston. In this virus, the substitution affected the ability of the P and V proteins to block type I interferon signaling (Devaux et al., 2006; Ohno et al., 2004) . The V protein has been demonstrated to regulate viral transcription in a mini-genome replication assay and amino acids 110-131 played a role in this activity (Witko et al., 2006) . Adaptation of a pathogenic wild-type strain of the closely related morbillivirus, canine distemper virus (CDV), to canine footpad keratinocytes induced mutations in the P/V/C and M proteins as well as the cytoplasmic tail of the H protein, similar to the results presented in our study (Rivals et al., 2006) .
Our results demonstrate that wild-type viruses can adapt to growth in Vero cells without amino acid changes in the H protein and without using CD46 as a receptor. Similar results have been reported for Vero cell-adaptation of MV (Kouomou and Wild, 2002; Nielsen et al., 2001; Takeuchi et al., 2000) and of CDV (Lednicky et al., 2004; Nielsen et al., 2003) . Cell culture-adapted measles viruses of the Edmonston lineage can use both hSLAM and CD46 as a receptor, and two substitutions in the H protein, Gln451Val and Asn481Tyr, have been implicated as being required for CD46 binding (Erlenhofer et al., 2002; Lecouturier et al., 1996) . The H proteins of Davis87wt and all four cell culture-adapted viruses share a Val at amino acid 451, but have Asn at position 481. The inability of the cell culture-adapted strains to infect CHO-CD46 cells indicates that none use CD46 as a receptor. Nevertheless, D-VI, D-VII, and D-CEF are able to infect Vero cells and replicate to high titers. These observations provide further support for the existence of a CD46-independent entry mechanism for Vero cells, possibly via an unknown third receptor (Andres et al., 2003; Takeuchi et al., 2002; Yanagi et al., 2006) . Other reports have presented evidence that the H proteins of wild-type viruses can bind CD46 with low affinity (Manchester et al., 2000; Masse et al., 2002) ; however, the inability of the viral stocks generated in this study to infect CHO-CD46 cells suggests that low affinity binding did not occur. The ability to use the unknown entry mechanism may be present in some wild-type viruses, since D-V/S could infect Vero cells and replicate, albeit inefficiently. Primary isolation of wild-type measles viruses on Vero cells has been reported, though the process is much more efficient in cell lines that express hSLAM (Kobune et al., 1990; Ono et al., 2001) . The difference in the ability to infect Vero cells observed between Davis87-wt and D-V/S was due to the 100-fold lower MOI used for infections with Davis87-wt. When infection with D-V/S was tested at the lower MOI, no signs of infection were detectable by indirect immunofluorescence assay (data not shown).
A search of the GenBank database did not identify any measles viruses that shared the predicted amino acid substitutions found in the cell culture-adapted viruses described here, with the exception of the change at amino acid 110 of the P and V proteins of D-CEF. No definitive nucleotide substitutions were found in any noncoding regions or in the F or L proteins of the cell culture-adapted viruses, suggesting that there is strong selective pressure on these regions of the genome of MV. The sequencing results demonstrated that some nucleotide positions in the cell culture-adapted viruses were heterogeneous. The viral subpopulations that carry the changes may be affected in their editing frequency (D-CEF, nucleotide 2499) (Hausmann et al., 1999; Jacques et al., 1994) or expression of the F protein (D-CEF, nucleotide 4873, 4874) (Barr et al., 1997; Stillman and Whitt, 1997) . However, these positions remained mixed after many passages suggesting that there is little selective advantage for either nucleotide and that their relevance for cell cultureadaptation may be low. It should be noted that the heterogeneous positions were detected because the sequence analysis program failed to call the base. It is likely that the base calling software did not identify other mixed positions.
Sequence analysis of the complete genomes of the Edmonston-derived vaccine strains detected nucleotide changes in both the coding and noncoding regions compared to the progenitor strain, Ed wt (Parks et al., 2001a,b) . Amino acid substitutions were found in all proteins and a total of eight amino acid changes were identified as common to all vaccine viruses compared to Ed-wt (Parks et al., 2001b) . Twenty-one nucleotide substitutions, including five nucleotide substitutions common to all vaccine strains, were found in the 3′ and 5′ noncoding regions and intergenic regions (Parks et al., 2001a) . In our attempt to repeat this process using viruses with defined levels of attenuation for rhesus macaques, we have identified a relatively smaller number of genetic changes that accompanied host cell adaptation. At present, we are exploring the consequences of the amino acid substitutions by using protein-specific, functional in vitro assays and by virus rescue.
Materials and methods
Cells and viruses
Vero, Vero/hSLAM, B95a, CHO, CHO-hSLAM, CHO-CD46 cells, and primary chicken embryo fibroblasts (CEF) were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, glutamine, penicillin, and streptomycin. Medium for CHO cells and derivative cell lines was further supplemented with MEM nonessential amino acids (Invitrogen). G418 sulfate (Cellgro) was used to maintain expression of hSLAM in Vero/hSLAM cells (0.4 mg/ml) and CD46 in CHO-CD46 (1 mg/ml). Zeocin (1 mg/ml, Invitrogen) was used to maintain expression of hSLAM in CHO-hSLAM cells. CHO-hSLAM and CHO-CD46 cell lines were a generous gift of Roberto Cattaneo, Rochester, MN. The Edmonston-Zagreb strain was provided by D. Ikic, Institute of Immunology, Zagreb, Croatia and propagated on Vero cells. The Davis87-wt stock was prepared as described previously . Starting materials for cell culture adaptation were passages C8 and C9 of Davis87-wt which had a titer of 5 × 10 3 plaque forming units (pfu)/ml in Vero/hSLAM cells.
Cell culture adaptation
Vero/hSLAM cells in 25 cm 2 flasks were infected with 25 pfu of Davis87-wt. When the cytopathic effect (CPE) involved most of the monolayer, cells were scraped into 1 ml of supernatant, frozen once at − 70°C and 0.5 μl used to infect a fresh culture. Vero cells in 25 cm 2 flasks were infected with 1000 pfu of Davis87-wt. CEF in 25 cm 2 flasks were infected with 2.1 × 10 6 pfu of D-V/S (MOI of 1). Vero cells and CEF were passaged every 5 days. When CPE involved most of the monolayer, cells were scraped into 1 ml of supernatant, frozen once at − 70°C and 10-50 μl used to infect a fresh culture, which was passaged until CPE developed. Viral titers of the small intermediate stocks were not measured. The viral titer of the final seed stock was determined and an MOI of 0.01 or less used to prepare larger stocks. Viral titers were measured by plaque assay on Vero/hSLAM cells. To generate a large stock of D-VII and D-CEF, the penultimate passage of infected cells was split by trypsinization to produce the final stock.
RNA preparation and sequence analysis
Total cellular RNA from infected cells and from 500 μl of the Davis87-wt stock was isolated using Trizol (Invitrogen). The MV genome was amplified in four overlapping fragments using primers based on the sequence of EdmBil (GenBank accession number Z66517; Radecke et al., 1995) . Reverse transcriptase reactions were performed using Superscript II reverse transcriptase (Invitrogen). PCR was performed with the Elongase enzyme mix (Invitrogen) according to manufacturer's recommendations for long PCR. The sequence of the termini was obtained by using a 5′ RACE kit (Invitrogen). The PCR product representing the 5′ terminus of the genome (trailer) was sequenced directly. The PCR product representing the 5′ terminus of the antigenome (leader complement) was cloned into the TA cloning vector (Invitrogen) and 10 clones containing the complete terminus were sequenced. Fragments were sequenced with the Big Dye Terminator v1.1 Cycle Sequencing kit (Applied Biosystems) using primers based on the EdmBil sequence. Primer sequences are available upon request. To verify the continued presence of nucleotide substitutions in cell culture-adapted viruses following passage in rhesus macaques, 1 × 10 5 PBMC were isolated from blood taken on day seven after infection and RNA was extracted with the Totally RNA kit (Ambion). The Superscript One-step RT/PCR kit (Invitrogen) was used to amplify small (300-500) bp PCR fragments containing the substitutions identified in the cell culture-adapted strains. Presence of the substitutions was verified by sequencing the PCR products. All sequence data were analyzed with the Sequencher program (Gene Codes Corporation) and version 11.1 of the sequence analysis software package of the University of Wisconsin Genetics Computer Group (Devereux et al., 1984) . GenBank accession numbers are EU293548, EU293549, EU293550, EU293551, and EU293552.
Immunofluorescence assays
Cells were seeded on chamber slides (NalgeNunc LabTek) and infected with an MOI of 0.1 of the cell culture-adapted strains or an MOI of 0.001 of Davis87-wt because of its low titer. Cells were fixed with 3.7% formaldehyde (Fisher Scientific) in PBS for 5 min at RT, followed by permeabilization with 0.25% Triton-X-100 (Sigma) in PBS for 15 min at RT. A monoclonal antibody directed against MV N protein was used for detection (Chemicon), followed by an Oregon green-labeled goat anti-mouse secondary antibody (Molecular Probes). For counterstaining, 0.5 μg/ml propidium iodide (Molecular Probes) was added to the secondary antibody dilution. A SPOT RT camera (Diagnostic Instruments) and the SPOT Advanced program were used for photography. Separate photos of the green and red fluorescence were merged using the SPOT Advanced program.
Growth curve measurements
Vero cells in 6 well dishes (Corning) were infected at an MOI of 0.01. At various time points post infection, supernatant was cleared of floating cells by centrifugation for 5 min at 500×g at 4°C in a tabletop centrifuge. Cells were scraped into 1 ml of fresh medium and cells or supernatants frozen once at − 70°C. Viral titers were determined by inoculating CHO-hSLAM cells in 96 well dishes with serial 10-fold dilutions of the sample. After 3 days of incubation at 37°C, CPE was detected by staining with crystal violet-formaldehyde (0.013% crystal violet, 2.5% ethanol, 10% formaldehyde in 0.01 M PBS) for 5 min at room temperature. CHO-hSLAM cells were chosen for titration since MV infection causes increased cell lysis compared to Vero-hSLAM cells, which simplifies detection of CPE. TCID 50 (50% tissue culture infectious dose) was determined using the method of Reed and Muench (Reed and Muench, 1938) .
Infection of rhesus macaques and titration on Raji cells
Colony-bred male and female juvenile rhesus macaques (Macaca mulatta), seronegative for measles virus, simian type D retroviruses, simian T-cell lymphotrophic virus, and simian immunodeficiency virus, were housed in accordance with the American Association for Accreditation of Laboratory Animals Care. The investigators adhered to the guidelines of the Committee on Care and Use of Laboratory Animals, National Research Council. For each virus tested, four animals were inoculated conjunctivally and intranasally with 3.2 × 10 4 TCID 50 as described . Infectious center assays to quantitate viremia were carried out on Raji cells as described previously . One week after MV inoculation, all animals were vaccinated subcutaneously with unconcentrated tetanus toxoid (Colorado Serum Company) at 20 μl/kg body weight. Tetanus antibody titers on days 0 and 21 were determined by ELISA as described (Premenko-Lanier et al., 2004) . A fourfold rise in titer was used as a cutoff value to determine significant changes in tetanus antibody titers.
